Lipid Management in Obesity

In this talk, Dr. Eugene Lucas of Weill Cornell Medicine will review the “Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients” study in context of today's lipid guidelines and management of patients at-risk of cardiovascular disease

Lipid Management in Obesity

Time & Location

Jun 14, 6:00 PM – 7:00 PM EDT

Zoom Webinar

About the Event

Dr. Eugene Lucas completed his undergraduate studies at the University of Scranton and his medical training at Drexel College of Medicine. After completing an Internal Medicine residency at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he completed a fellowship in Clinical Informatics at NewYork-Presbyterian Hospital and Columbia University Irving Medical Center. He is currently an Obesity Medicine Fellow at the Weill Cornell Medical Center and is board certified in Internal Medicine, Clinical Informatics, and Obesity Medicine.

Learning Objectives

  1. Understand the value of various lipoproteins in predicting risk for cardiovascular disease
  2. Understand the benefits of screening for elevated lipoprotein (a)

Tickets

Price

Quantity

Total

  • Free

    $0

    $0

    0

    $0

Total

$0

Share This Event